From Bench to Bedside: Dr. Nicola Mason and Her Research


Dr. Nicola Mason, B.Vet.Med, PhD, is a veterinarian, professor, principal investigator, but above all an animal lover. Her goal is to bring her cutting-edge research to your pet,from bench to bedside. Her research in immunotherapy has opened many new options for treating previously difficult diseases like cancer, to make sure your furry friend has a better life by your side.

Cancer is the leading cause of death in dogs over the age of 10. Currently, three main types of cancer treatment exist for dogs and cats – surgery, radiation, and chemotherapy. These treatments are used either alone or in combination to eliminate cancer cells from the body.

Despite these treatments, some cancer cells usually survive leading to disease relapse or progression. Unfortunately, most patients usually die of relapsed, drug-resistant metastatic disease.

Another type of therapy that is rapidly gaining attention in the treatment of cancer in people is immunotherapy. In this therapeutic approach, the patient’s own immune system is used to target and kill cancer cells in the body.

Dr. Nicola Mason B.Vet.Med., PhD, DACVIM, professor at Penn Vet, runs a translational research laboratory that focuses on ways to train the immune system to recognize and kill cancers in veterinary species.